Details for New Drug Application (NDA): 020068

✉ Email this page to a colleague

NDA 020068 describes FOSCAVIR, which is a drug marketed by Clinigen Hlthcare and is included in one NDA. It is available from one supplier. Additional details are available on the FOSCAVIR profile page.

The generic ingredient in FOSCAVIR is foscarnet sodium. There are seven drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the foscarnet sodium profile page.

Summary for 020068

Tradename:	FOSCAVIR
Applicant:	Clinigen Hlthcare
Ingredient:	foscarnet sodium
Patents:	0

Pharmacology for NDA: 020068

Mechanism of Action	Chelating Activity DNA Polymerase Inhibitors

Medical Subject Heading (MeSH) Categories for 020068

Antiviral Agents
Reverse Transcriptase Inhibitors

Suppliers and Packaging for NDA: 020068

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
FOSCAVIR	foscarnet sodium	INJECTABLE;INJECTION	020068	NDA	Clinigen Limited	76310-024	76310-024-01	10 CARTON in 1 CARTON (76310-024-01) / 1 BOTTLE in 1 CARTON (76310-024-11) / 250 mL in 1 BOTTLE
FOSCAVIR	foscarnet sodium	INJECTABLE;INJECTION	020068	NDA	Clinigen Limited	76310-024	76310-024-25	10 CARTON in 1 CARTON (76310-024-25) / 1 BOTTLE in 1 CARTON (76310-024-15) / 250 mL in 1 BOTTLE

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	INJECTABLE;INJECTION			Strength	2.4GM/100ML
Approval Date:	Sep 27, 1991	TE:	AP	RLD:	Yes

Expired US Patents for NDA 020068

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Clinigen Hlthcare	FOSCAVIR	foscarnet sodium	INJECTABLE;INJECTION	020068-001	Sep 27, 1991	⤷ Sign Up	⤷ Sign Up
Clinigen Hlthcare	FOSCAVIR	foscarnet sodium	INJECTABLE;INJECTION	020068-001	Sep 27, 1991	⤷ Sign Up	⤷ Sign Up
Clinigen Hlthcare	FOSCAVIR	foscarnet sodium	INJECTABLE;INJECTION	020068-001	Sep 27, 1991	⤷ Sign Up	⤷ Sign Up
Clinigen Hlthcare	FOSCAVIR	foscarnet sodium	INJECTABLE;INJECTION	020068-001	Sep 27, 1991	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.